SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 1, 2005
QuadraMed Corporation
(Exact name of registrant as specified in its charter)
| | | | |
| Delaware | | 0-21031 | | 52-1992861 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
12110 Sunset Hills Road, Suite 600, Reston, VA 20190
(Address of principal executive office and zip code)
(703) 709-2300
(Registrant’s telephone number, including area code)
(Not Applicable)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
TABLE OF CONTENTS
Item 1.02 Termination of a Material Definitive Agreement.
Pursuant to notice delivered to QuadraMed Corporation on July 1, 2005, Frank J. Pecaitis will resign as the Company’s Senior Vice President, Client Development, and terminate his Employment Agreement with the Company effective July 15, 2005. Lawrence P. English, the Company’s Chief Executive Officer, will assume Mr. Pecaitis’ duties as the Company conducts a search for his replacement.
On July 5, 2005, the Company issued a press release announcing Mr. Pecaitis’ resignation. A copy of this press release is furnished as Exhibit 99.1 and is incorporated herein by reference to this Item 1.02.
Item 9.01 Financial Statements and Exhibits.
(c) Exhibit
| | |
| Exhibit 99.1 | | QuadraMed Corporation Press Release, dated July 5, 2005. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: July 7, 2005
|
| QuadraMed Corporation |
|
/s/ John C. Wright
|
John C. Wright |
Executive Vice President and Chief Financial Officer |
EXHIBIT INDEX
| | |
Exhibit No.
| | Description
|
| 99.1 | | QuadraMed Corporation Press Release, dated July 5, 2005. |
